Connor Clark & Lunn Investment Management Ltd. decreased its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) by 31.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,713 shares of the company’s stock after selling 12,067 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Ryan Specialty were worth $1,707,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of RYAN. Hollencrest Capital Management bought a new position in Ryan Specialty during the third quarter worth about $25,000. Assetmark Inc. acquired a new stake in shares of Ryan Specialty in the third quarter valued at approximately $34,000. GAMMA Investing LLC grew its position in Ryan Specialty by 96.4% during the second quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock worth $35,000 after buying an additional 297 shares in the last quarter. Crewe Advisors LLC acquired a new stake in Ryan Specialty during the second quarter worth approximately $39,000. Finally, Signaturefd LLC increased its stake in Ryan Specialty by 12.3% during the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after acquiring an additional 148 shares during the period. Institutional investors and hedge funds own 84.82% of the company’s stock.
Insider Transactions at Ryan Specialty
In related news, EVP Mark Stephen Katz sold 14,790 shares of Ryan Specialty stock in a transaction on Friday, November 8th. The shares were sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the completion of the transaction, the executive vice president now owns 12,386 shares of the company’s stock, valued at $884,236.54. This trade represents a 54.42 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Nicholas Dominic Cortezi sold 5,375 shares of the company’s stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $64.73, for a total transaction of $347,923.75. Following the sale, the director now directly owns 2,685 shares in the company, valued at $173,800.05. This trade represents a 66.69 % decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is owned by company insiders.
Ryan Specialty Trading Up 1.4 %
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, hitting the consensus estimate of $0.41. The company had revenue of $604.69 million for the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business’s quarterly revenue was up 20.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.32 earnings per share. As a group, sell-side analysts expect that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current fiscal year.
Ryan Specialty Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be issued a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.59%. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on the company. Barclays increased their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $65.00 to $75.00 in a research note on Tuesday, September 24th. Wells Fargo & Company boosted their target price on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research report on Thursday, October 10th. The Goldman Sachs Group increased their price target on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 9th. Finally, Bank of America boosted their price objective on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $71.67.
View Our Latest Stock Analysis on RYAN
Ryan Specialty Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also
- Five stocks we like better than Ryan Specialty
- Stock Analyst Ratings and Canadian Analyst Ratings
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Short Selling: How to Short a Stock
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- What is Insider Trading? What You Can Learn from Insider Trading
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.